| scholarly article | Q13442814 |
| P356 | DOI | 10.1055/S-0035-1562894 |
| P698 | PubMed publication ID | 26398534 |
| P50 | author | Nathan Paul Wiederhold | Q42104169 |
| Thomas F Patterson | Q56859142 | ||
| P2093 | author name string | Nathan P Wiederhold | |
| P433 | issue | 5 | |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 673-680 | |
| P577 | publication date | 2015-09-23 | |
| P1433 | published in | Seminars in Respiratory and Critical Care Medicine | Q15751823 |
| P1476 | title | Emergence of Azole Resistance in Aspergillus | |
| P478 | volume | 36 |
| Q61806734 | APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis |
| Q40215709 | Azole-resistant Aspergillus fumigatus in sawmills of Eastern France. |
| Q38905119 | Central Role of the Trehalose Biosynthesis Pathway in the Pathogenesis of Human Fungal Infections: Opportunities and Challenges for Therapeutic Development |
| Q40045673 | Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification |
| Q92575576 | Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus |
| Q64940476 | Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man. |
| Q54225700 | Heavy Metal-Induced Expression of PcaA Provides Cadmium Tolerance to Aspergillus fumigatus and Supports Its Virulence in the Galleria mellonella Model. |
| Q40225550 | Hepatotoxicity of Antimycotics Used for Invasive Fungal Infections: In Vitro Results. |
| Q93102983 | Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC® Natural Adjuvant against Aspergillosis |
| Q52725979 | Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based Assays. |
| Q46307503 | Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species |
| Q91803592 | New Insights into the Cyp51 Contribution to Azole Resistance in Aspergillus Section Nigri |
| Q40119990 | Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a cyp51A TR46 Y121F M172I T289A Allele |
| Q49176959 | Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States |
| Q47282129 | Scanning Quadrupole Data-Independent Acquisition, Part B: Application to the Analysis of the Calcineurin-Interacting Proteins during Treatment of Aspergillus fumigatus with Azole and Echinocandin Antifungal Drugs |
| Q38833311 | Sphingolipids as targets for treatment of fungal infections |
| Q40045635 | The Role of In Vitro Susceptibility Testing in the Management of Candida and Aspergillus |
| Q26746016 | Therapeutic Drug Monitoring of Posaconazole: an Update |
| Q37581266 | Updated guidelines for the diagnosis and management of aspergillosis |
| Q90632874 | Voriconazole-Based Salts Are Active against Multidrug-Resistant Human Pathogenic Yeasts |
Search more.